In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they intend to reclassify marijuana being a Plan III drug. This rescheduling will acknowledge that cannabis has legitimate clinical purposes and should help open the door to investigation on other likely treatment uses.Just after a comprehensive review of numerous leading makes for b